Trademark: 74364436
Word
TOLERANCE TECHNOLOGY
Status
Dead
Status Code
710
Status Date
Friday, April 3, 2020
Serial Number
74364436
Registration Number
1886506
Registration Date
Tuesday, March 28, 1995
Mark Type
1000
Filing Date
Wednesday, March 3, 1993
Published for Opposition
Tuesday, September 14, 1993
Cancellation Date
Friday, April 3, 2020

Trademark Owner History
LA JOLLA PHARMACEUTICAL COMPANY - Original Registrant

Classifications
5 pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases; namely, systemic lupus erythematosus; Rh hemolytic disease of the newborn; antiphospholipid antibody syndrome; grave's disease; myasthenia gravis; hashimoto's thyroiditis; pemphigus; autoimmune hemolytic anemia; autoimmune thrombocytopenia purpura; antibody mediated infertility; sjogre's syndrome; mixed connective tissue disease; glomerulonephritis and goodpasture's syndrome

Trademark Events
Apr 3, 2020
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Apr 14, 2005
Registered And Renewed (First Renewal - 10 Yrs)
Apr 14, 2005
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Mar 7, 2005
Registered - Combined Section 8 (10-Yr) & Sec. 9 Filed
Mar 7, 2005
Paper Received
Jun 12, 2001
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Mar 28, 2001
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Mar 28, 1995
Registered-Principal Register
Dec 21, 1994
Allowed Principal Register - Sou Accepted
Nov 30, 1994
Statement Of Use Processing Complete
Oct 20, 1994
Use Amendment Filed
Jun 8, 1994
Extension 1 Granted
May 6, 1994
Extension 1 Filed
Dec 7, 1993
Noa Mailed - Sou Required From Applicant
Sep 14, 1993
Published For Opposition
Aug 13, 1993
Notice Of Publication
Jun 25, 1993
Approved For Pub - Principal Register
Jun 18, 1993
Previous Allowance Count Withdrawn
Jun 1, 1993
Approved For Pub - Principal Register
May 21, 1993
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24